Company Search:
Advanced Search
Sponsored Links
Arcus Biosciences Inc Company Snapshot
Arcus Biosciences Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arcus Biosciences Inc with three other companies in this sector in the United States: Kalvista Pharmaceuticals Inc (2018 sales of $8.39 million ), Redhill Biopharma Ltd ($8.36 million ), and Miragen Therapeutics Inc ($8.39 million of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Arcus Biosciences Inc
  Stock Performance Chart for Arcus Biosciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 7.54
(Figures in U.S. Dollars)
1 Week -7.5%   13 Weeks -8.0%  
4 Weeks 3.6%   52 Weeks -38.5%  
Arcus Biosciences Inc Key Data:
  Ticker: RCUS Country: United States
  Exchanges: NYSE Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 8,353,000
(Year Ending Jan 2019).
Employees: 108
  Currency: U.S. Dollars Market Cap: 345,655,964
  Fiscal Yr Ends: December Shares Outstanding: 45,842,966
  Share Type: Common Closely Held Shares: 16,134,374
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.